Gout is the most common inflammatory arthritis affecting 1-2% of the population. It is a very common problem presenting to ...

GLP-1 receptor agonist use in adults with concurrent type 2 diabetes and obesity was associated with increased risk for ...

A medication commonly used to treat gout could be the key to reducing a cardiovascular condition that puts one in five people aged over 75 at risk of ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. A Passion for Issues that Matter to Americans 50-Plus is All You ...

Women survive advanced cancers longer than men, but endure more severe toxic side effects from cancer treatments, reveals new analysis.

Company to host conference call and webcast today at 8:00 a.m. EDT The European Commission (EC) approved the 2mg/kg every-4-weeks (E4W) dosing regimen for Elfabrio® ...

The Shenzhen, China-based biotech plans to launch a Phase I trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of IN026.

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.

New world champion Torrie Lewis is on a collision course to face the drug cheat who initially denied her gold after seven ...

A pattern of musculoskeletal injuries spurred researchers to conduct a study on whether using the popular weight-loss and diabetes drugs increased a person’s risk of other health conditions.